Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Daugaard

Showing results (51-60 of 54) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 54 results.
European Journal of Cancer (Oxford, England : 1990)|August 8, 2006
Phase 1 European Organisation for Research and Treatment of Cancer study determining safety of pegylated liposomal doxorubicin (Caelyx) in combination with ifosfamide in previously untreated adult patients with advanced or metastatic soft tissue sarcomasO S Nielsen, P Reichardt, T B Christensen, et al.
British Journal of Cancer|December 23, 1998
High-dose epirubicin is not an alternative to standard-dose doxorubicin in the treatment of advanced soft tissue sarcomas. A study of the EORTC soft tissue and bone sarcoma groupO S Nielsen, P Dombernowsky, H Mouridsen, et al.
European Journal of Cancer (Oxford, England : 1990)|March 6, 2007
Exatecan in pretreated adult patients with advanced soft tissue sarcoma: results of a phase II--study of the EORTC Soft Tissue and Bone Sarcoma GroupP Reichardt, O S Nielsen, S Bauer, et al.
International Archives of Occupational and Environmental Health|July 7, 2014
Individual and work-unit measures of psychological demands and decision latitude and the use of antihypertensive medicationS Daugaard, J H Andersen, M B Grynderup, et al.
Pageof 6

Showing results (51-60 of 54) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 54 results.
European Journal of Cancer (Oxford, England : 1990)|August 8, 2006
Phase 1 European Organisation for Research and Treatment of Cancer study determining safety of pegylated liposomal doxorubicin (Caelyx) in combination with ifosfamide in previously untreated adult patients with advanced or metastatic soft tissue sarcomasO S Nielsen, P Reichardt, T B Christensen, et al.
British Journal of Cancer|December 23, 1998
High-dose epirubicin is not an alternative to standard-dose doxorubicin in the treatment of advanced soft tissue sarcomas. A study of the EORTC soft tissue and bone sarcoma groupO S Nielsen, P Dombernowsky, H Mouridsen, et al.
European Journal of Cancer (Oxford, England : 1990)|March 6, 2007
Exatecan in pretreated adult patients with advanced soft tissue sarcoma: results of a phase II--study of the EORTC Soft Tissue and Bone Sarcoma GroupP Reichardt, O S Nielsen, S Bauer, et al.
International Archives of Occupational and Environmental Health|July 7, 2014
Individual and work-unit measures of psychological demands and decision latitude and the use of antihypertensive medicationS Daugaard, J H Andersen, M B Grynderup, et al.
Pageof 6